started poppiing .0112 now
MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) is pleased to announce the issuance of U.S. patent 7,935,528 by the United States Patent and Trademark Office (USPTO) relating to the isolation and use of human liver stem cells to treat liver disease. Under the terms of its license agreement with Rhode Island Hospital, MultiCell Technologies is the worldwide exclusive licensee of U.S. patent 7,935,528.
The patent describes methods to isolate and use human liver stem cells to treat degenerative liver diseases, or inherited deficiencies of liver function. Patients who suffer from severe, irreversible liver disease for which other medical and surgical treatments have failed are often candidates for a liver transplant. Liver stem cells which differentiate into functional mature hepatocytes could help to reconstitute a diseased liver, and may be an alternative approach to whole organ transplants for certain liver diseases.
"We are pleased the USPTO has agreed that our liver stem cells are indeed novel and may lead to important therapeutic applications," said W. Gerald Newmin, Chairman and Chief Executive Officer. "Our efforts to better understand liver stem cell biology, and the role these cells play in chronic liver disease and primary hepatocellular carcinoma, is a major focus of the Company," Mr. Newmin stated.
About MultiCell Technologies, Inc.
MultiCell Technologies, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics and discovery tools that address unmet medical needs for the treatment of neurological disorders, hepatic disease and cancer. For more information about MultiCell Technologies, please visit http://www.multicelltech.com.
WDRP .05 ish now,
seems like there is a bit of work left to be done, but this could fly soon
There is another fuel spec, approved some time ago, which relates to bio-based fuels produced using the Fischer-Tropsch process. Rentech is among the leading companies producing this fuel, which is already approved for use and was the subject of a 13-airline offtake agreement at LAX, announced last year. Rentech is also working with UOP for unionfining, unicracking and dewaxing technologies.
In addition, several companies are developing technologies that will produce jet fuels directly from fermentation, or from catalytic conversion processes. Companies pursuing this track include Cobalt Technologies, Gevo, Amyris, Joule Unlimited, and Virent. The latest guidance from Amyris suggests that they expect to see approval and commercial-scale production of those fuels by mid-decade.
about $5- for the future- maybe 20, 30 years- yay